XML 398 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Components of Income Tax Expense Benefit Income before income taxes and equity in net income of unconsolidated investments, and current and deferred income tax expense (benefit) are composed of the following (in thousands):
Year Ended December 31,
202320222021
Income before income taxes and equity in net income of unconsolidated investments:
Domestic$(461,897)$952,799 $(186,077)
Foreign708,635 1,480,645 319,695 
Total$246,738 $2,433,444 $133,618 
Current income tax expense (benefit):
Federal$(54,250)$33,230 $11,722 
State(3,395)4,965 694 
Foreign387,045 259,054 55,530 
Total$329,400 $297,249 $67,946 
Deferred income tax expense (benefit):
Federal$(8,545)$84,054 $(38,413)
State(4,154)(3,511)(5,544)
Foreign113,576 12,796 5,457 
Total$100,877 $93,339 $(38,500)
Total income tax expense$430,277 $390,588 $29,446 
Significant Differences Between United States Federal Statutory Rate and Effective Income Tax Rate
The reconciliation of the U.S. federal statutory rate to the effective income tax rate is as follows:
% of Income Before Income Taxes
202320222021
Federal statutory rate21.0 %21.0 %21.0 %
State taxes, net of federal tax benefit(2.8)— (3.5)
Change in valuation allowance(a)
98.8 (3.9)33.7 
Impact of foreign earnings, net(b)(c)
7.7 (0.1)(40.5)
Global intangible low tax inclusion4.2 0.3 12.3 
Foreign-derived intangible income— (3.0)— 
Section 162(m) limitation4.4 0.3 4.5 
Subpart F income(1.9)0.2 4.8 
Stock-based compensation(3.9)(0.3)(7.2)
Depletion(2.4)(0.2)(2.9)
U.S. federal return to provision(6.1)(0.4)(1.7)
Revaluation of unrecognized tax benefits/reserve requirements(d)
39.1 2.3 3.0 
Legal accrual(e)
18.6 — — 
Other items, net(2.3)(0.1)(1.5)
Effective income tax rate174.4 %16.1 %22.0 %
(a)Due to the Company being in a three-year cumulative loss position in China as of December 31, 2023, the year ended December 31, 2023 includes the establishment of a valuation allowance of $223.0 million on current year losses in one of our Chinese entities. The years ended December 31, 2022 and 2021 include benefits of $91.8 million and $6.0 million, respectively, due to the release of a foreign valuation allowance due to changes in expected profitability.
(b)The year ended December 31, 2021 includes a discrete tax benefit of $27.9 million related to the revision of an indemnification estimate for an ongoing tax-related matter in Germany.
(c)Our statutory rate is decreased by our share of the income of JBC, a Free Zones company under the laws of the Hashemite Kingdom of Jordan. The applicable provisions of the Jordanian law, and applicable regulations thereunder, do not have a termination provision and the exemption is indefinite. As a Free Zones company, JBC is not subject to income taxes on the profits of products exported from Jordan, and currently, substantially all of the profits are from exports. This resulted in a rate benefit of 20.1%, 3.2%, and 34.6% for the years ended December 31, 2023, 2022, and 2021, respectively.
(d)The year ended December 31, 2023 includes a $96.5 million expense recorded for a current year tax reserve related to an uncertain tax position in Chile.
(e)The year ended December 31, 2023 includes the tax impact of a non-deductible $218.5 million legal accrual recorded for the agreements to resolve a previously disclosed legal matter with the DOJ and SEC during the year ended December 31, 2023. See Note 17, “Commitments and Contingencies,” for further details on this matter.
Deferred Income Tax Assets and Liabilities Recorded on Consolidated Balance Sheets
Deferred income tax assets and liabilities recorded on the consolidated balance sheets as of December 31, 2023 and 2022 consist of the following (in thousands):
December 31,
20232022
Deferred tax assets:
Accrued employee benefits$31,917 $20,060 
Operating loss carryovers1,316,916 1,157,841 
Pensions23,527 26,229 
Inventory reserves83,136 3,600 
Tax credit carryovers1,431 3,750 
Other(a)
103,517 118,733 
Gross deferred tax assets1,560,444 1,330,213 
Valuation allowance(1,349,924)(1,087,505)
Deferred tax assets210,520 242,708 
Deferred tax liabilities:
Depreciation(541,245)(446,942)
Intangibles(54,413)(84,690)
Other(150,859)(145,412)
Deferred tax liabilities(746,517)(677,044)
Net deferred tax liabilities$(535,997)$(434,336)
Classification in the consolidated balance sheets:
Noncurrent deferred tax assets$22,433 $46,434 
Noncurrent deferred tax liabilities(558,430)(480,770)
Net deferred tax liabilities$(535,997)$(434,336)
Changes in Balance of Deferred Tax Asset Valuation Allowance
Changes in the balance of our deferred tax asset valuation allowance are as follows (in thousands):
Year Ended December 31,
202320222021
Balance at January 1$(1,087,505)$(1,276,305)$(1,326,204)
Additions(262,469)(5,810)(61,470)
Deductions50 194,610 111,369 
Balance at December 31$(1,349,924)$(1,087,505)$(1,276,305)
Reconciliation of Total Gross Liability Related to Uncertain Tax Positions The following is a reconciliation of our total gross liability related to uncertain tax positions for 2023, 2022 and 2021 (in thousands):
Year Ended December 31,
202320222021
Balance at January 1$72,162 $20,717 $11,639 
Additions for tax positions related to prior years6,216 1,673 75 
Reductions for tax positions related to prior years— — (6)
Additions for tax positions related to current year101,179 50,531 10,911 
Lapses in statutes of limitations/settlements(770)(995)(1,931)
Foreign currency translation adjustment(2)236 29 
Balance at December 31$178,785 $72,162 $20,717